Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001209191-23-053982

Options or other derivatives

  • Chief Medical Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lechleider Robert Chief Medical Officer 2023-10-27 Grant or award · Stock option (right to buy) +400,000 400,000 D: show line 1 in the form
Loading xslF345X05/doc4.xml…